Cambridge drug discovery firm CN Bio raises £17m
Related Articles
-
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […] © 2024 TechCrunch. All rights reserved. For personal use only.
-
Nutriband raises millions for drug abuse deterrent product
Founded by Dubliner Gareth Sheridan, Nutriband listed on Nasdaq in October 2021. Now, its flagship opioid patch product is a step closer to getting FDA approval. : Nutriband raises millions for drug abuse deterrent product
-
General Catalyst Reportedly Raises Nearly $6 Billion for Tech Firms
Venture capital (VC) operation General Catalyst has reportedly raised almost $6 billion for technology startups. The company, which has invested in Stripe, Snap and Mistral, could close its newest fund as soon as May, the Financial Times reported Sunday (April 28), citing sources familiar with the matter who say the funds will be invested in various sectors including defense, space, climate, […]